Epigenetic changes in estrogen receptor β gene in atherosclerotic cardiovascular tissues and in-vitro vascular senescence

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1772, Issue 1, 2007, Pages 72-80

  Kim, Jei ^a,b   Kim, Jee Yeon ^b   Song, Kyu Sang ^b   Lee, Young Ho ^b   Seo, Joong Seok ^c   Jelinek, Jaroslav ^a   Goldschmidt Clermont, Pascal J ^d   Issa, Jean Pierre J ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b Chungnam National University   (South Korea)

^c National Institute of Scientific Investigation   (South Korea)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Aging; Atherosclerosis; DNA methylation; Epigenetic dysregulation; Estrogen receptor beta; In vitro senescence

Indexed keywords

DNA METHYLTRANSFERASE; ESTROGEN RECEPTOR BETA; HISTONE;

ADULT; AGING; ARTICLE; ASCENDING AORTA; ATHEROSCLEROSIS; CASE REPORT; COMMON CAROTID ARTERY; CORONARY ARTERY ATHEROSCLEROSIS; CPG ISLAND; DEACETYLATION; DEMETHYLATION; DNA METHYLATION; ENDOTHELIUM CELL; ENZYME INHIBITION; EPIGENETICS; FEMALE; FEMORAL ARTERY; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATORY CELL; MACROPHAGE; MALE; MONOCYTE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER; STATISTICAL ANALYSIS;

ARTERIES; ATHEROSCLEROSIS; CELL AGING; CELL LINE; CELLS, CULTURED; DNA METHYLATION; ENDOTHELIAL CELLS; ENZYME INHIBITORS; EPIGENESIS, GENETIC; ESTROGEN RECEPTOR BETA; FEMALE; GENE EXPRESSION; HUMANS; MALE; MUSCLE, SMOOTH, VASCULAR; PROMOTER REGIONS (GENETICS);

EID: 33845647686     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2006.10.004     Document Type: Article

References (23)

1. Bird A.P. CpG-rich islands and the function of DNA methylation. Nature 321 (1986) 209-213
2. Issa J.-P.J. Aging, DNA methylation, and cancer. Crit. Rev. Oncol./Hematol. 32 (1999) 31-43
3. Issa J.-P.J., Ottaviano Y.L., Celano P., Hamilton S.R., Davidson N.E., and Baylin S.B. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat. Genet. 7 (1994) 536-540
4. Mendelsohn M.E., and Karas R.H. The protective effects of estrogen on the cardiovascular system. N. Engl. J. Med. 340 (1999) 1801-1811
5. Venkov C.D., Rankin A.B., and Vaughan D.E. Identification of authentic estrogen receptor in cultured endothelial cells. A potential mechanism for steroid hormone regulation of endothelial function. Circulation 94 (1996) 727-733
6. Lindner V., Kim S.K., Karas R.H., Kuiper G.G., Gustafsson J.A., and Mendelsohn M.E. Increased expression of estrogen receptor-beta mRNA in male blood vessels after vascular injury. Circ. Res. 83 (1998) 224-229
7. Zhu Y., Bian Z., Lu P., Karas R.H., Bao L., Cox D., Hodgin J., Shaul P.W., Thoren P., Smithies O., Gustafsson J.A., and Mendelsohn M.E. Abnormal vascular function and hypertension in mice deficient in estrogen receptor beta. Science 295 (2002) 505-508
8. Ying A.K., Hassanain H.H., Roos C.M., Smiraglia D.J., Issa J.J., Michler R.E., Caligiuri M., Plass C., and Goldschmidt-Clermont P.J. Methylation of the estrogen receptor-alpha gene promoter is selectively increased in proliferating human aortic smooth muscle cells. Cardiovasc. Res. 46 (2000) 172-179
9. Post W.S., Goldschmidt-Clermont P.J., Wilhide C.C., Heldman A.W., Sussman M.S., Ouyang P., Milliken E.E., and Issa J.P. Methylation of the estrogen receptor gene is associated with aging and atherosclerosis in the cardiovascular system. Cardiovasc. Res. 43 (1999) 985-991
10. Herman J.G., Graff J.R., Myohanen S., Nelkin B.D., and Baylin S.B. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 9821-9826
11. Xiong Z., and Laird P.W. COBRA: a sensitive and quantitative DNA methylation assay. Nucleic Acids Res. 25 (1997) 2532-2534
12. Mosselman S., Polman J., and Dijkema R. ER beta: identification and characterization of a novel human estrogen receptor. FEBS Lett. 392 (1996) 49-53
13. Warnecke P.M., Stirzaker C., Melki J.R., Millar D.S., Paul C.L., and Clark S.J. Detection and measurement of PCR bias in quantitative methylation analysis of bisulphite-treated DNA. Nucleic Acids Res. 25 (1997) 4422-4426
14. Wilson V.L., and Jones P.A. DNA methylation decreases in aging but not in immortal cells. Science 220 (1983) 055-1057
15. Baylin S.B., Herman J.G., Graff J.R., Vertino P.M., and Issa J.-P.J. Alterations in DNA methylation-A fundamental aspect of neoplasia. Adv. Cancer Res. 72 (1998) 141-196
16. Hiltunen M.O., Turunen M.P., Hakkinen T.P., Rutanen J., Hedman M., Makinen K., Turunen A.M., Aalto-Setala K., and Yla-Herttuala S. DNA hypomethylation and methyltransferase expression in atherosclerotic lesions. Vasc. Med. 7 (2002) 5-11
17. Schwartz S.M., and Murry C.E. Proliferation and the monoclonal origins of atherosclerotic lesions. Annu. Rev. Med. 49 (1998) 437-460
18. Manson J.E., and Martin K.A. Clinical practice. Postmenopausal hormone-replacement therapy. N. Engl. J. Med. 345 (2001) 34-40
19. Viscoli C.M., Brass L.M., Kernan W.N., Sarrel P.M., Suissa S., and Horwitz R.I. A clinical trial of estrogen-replacement therapy after ischemic stroke. N. Engl. J. Med. 345 (2001) 1243-1249
20. Kuromitsu J., Kataoka H., Yamashita H., Muramatsu M., Furuichi Y., Sekine T., and Hayashizaki Y. Reproducible alterations of DNA methylation at a specific population of CpG islands during blast formation of peripheral blood lymphocytes. DNA Res. 2 (1995) 263-267
21. Cameron E.E., Bachman K.E., Myohanen S., Herman J.G., and Baylin S.B. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nat. Genet. 21 (1999) 103-107
22. Bender C.M., Pao M.M., and Jones P.A. Inhibition of DNA methylation by 5-aza-2'-deoxycytidine suppresses the growth of human tumor cell lines. Cancer Res. 58 (1998) 95-101
23. Manson J.E., Hsia J., Johnson K.C., Rossouw J.E., Assaf A.R., Lasser N.L., Trevisan M., Black H.R., Heckbert S.R., Detrano R., Strickland O.L., Wong N.D., Crouse J.R., Stein E., and Cushman M. Estrogen plus progestin and the risk of coronary heart disease. N. Engl. J. Med. 349 (2003) 523-534